Factors to considered in the selection of hepatitis reduced products for clinical trial - Evaluation of residual infectivity for HCV viruses, by J Craske, Chairman, UK Haemophilia Centre Directors Hepatitis Working Party. Concerns chemical-treated plasma, pasteurisation of blood products, infectivity of foreign products, and AIDS in US plasma